nodes	percent_of_prediction	percent_of_DWPC	metapath
Diltiazem—CYP2D6—Hydroxyurea—head and neck cancer	0.155	0.192	CbGbCtD
Diltiazem—CYP3A7—Docetaxel—head and neck cancer	0.0983	0.122	CbGbCtD
Diltiazem—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0983	0.122	CbGbCtD
Diltiazem—CYP2C8—Fluorouracil—head and neck cancer	0.0928	0.115	CbGbCtD
Diltiazem—CYP3A5—Docetaxel—head and neck cancer	0.0737	0.0913	CbGbCtD
Diltiazem—CYP2C9—Fluorouracil—head and neck cancer	0.0648	0.0802	CbGbCtD
Diltiazem—ABCB1—Vinblastine—head and neck cancer	0.0582	0.0721	CbGbCtD
Diltiazem—CYP2D6—Vinblastine—head and neck cancer	0.0549	0.0679	CbGbCtD
Diltiazem—ABCB1—Docetaxel—head and neck cancer	0.048	0.0594	CbGbCtD
Diltiazem—CYP3A4—Vinblastine—head and neck cancer	0.0349	0.0432	CbGbCtD
Diltiazem—CYP3A4—Docetaxel—head and neck cancer	0.0288	0.0356	CbGbCtD
Diltiazem—Edema of lower extremities—Docetaxel—head and neck cancer	0.00616	0.0335	CcSEcCtD
Diltiazem—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.004	0.0218	CcSEcCtD
Diltiazem—Parkinsonism—Fluorouracil—head and neck cancer	0.00377	0.0205	CcSEcCtD
Diltiazem—Rash generalised—Docetaxel—head and neck cancer	0.00291	0.0158	CcSEcCtD
Diltiazem—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00288	0.0157	CcSEcCtD
Diltiazem—Bone pain—Vinblastine—head and neck cancer	0.00272	0.0148	CcSEcCtD
Diltiazem—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.00256	0.014	CcSEcCtD
Diltiazem—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00242	0.0132	CcSEcCtD
Diltiazem—Phlebitis—Vinblastine—head and neck cancer	0.0022	0.012	CcSEcCtD
Diltiazem—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.00213	0.0116	CcSEcCtD
Diltiazem—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00208	0.0113	CcSEcCtD
Diltiazem—Eye irritation—Fluorouracil—head and neck cancer	0.00201	0.0109	CcSEcCtD
Diltiazem—Dermatitis contact—Fluorouracil—head and neck cancer	0.00169	0.00922	CcSEcCtD
Diltiazem—Face oedema—Hydroxyurea—head and neck cancer	0.00167	0.00908	CcSEcCtD
Diltiazem—Otitis media—Docetaxel—head and neck cancer	0.00159	0.00864	CcSEcCtD
Diltiazem—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00154	0.00837	CcSEcCtD
Diltiazem—Eye irritation—Docetaxel—head and neck cancer	0.00145	0.00788	CcSEcCtD
Diltiazem—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00144	0.00783	CcSEcCtD
Diltiazem—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00143	0.00779	CcSEcCtD
Diltiazem—Myocardial infarction—Vinblastine—head and neck cancer	0.00143	0.00779	CcSEcCtD
Diltiazem—Photosensitivity—Fluorouracil—head and neck cancer	0.00142	0.00771	CcSEcCtD
Diltiazem—Swelling—Fluorouracil—head and neck cancer	0.00141	0.00767	CcSEcCtD
Diltiazem—Agranulocytosis—Vinblastine—head and neck cancer	0.00136	0.00742	CcSEcCtD
Diltiazem—Weight increased—Hydroxyurea—head and neck cancer	0.00136	0.0074	CcSEcCtD
Diltiazem—Amnesia—Fluorouracil—head and neck cancer	0.00132	0.0072	CcSEcCtD
Diltiazem—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.0013	0.0071	CcSEcCtD
Diltiazem—Pharyngitis—Vinblastine—head and neck cancer	0.0013	0.00708	CcSEcCtD
Diltiazem—Bone pain—Docetaxel—head and neck cancer	0.00129	0.00703	CcSEcCtD
Diltiazem—Lethargy—Fluorouracil—head and neck cancer	0.00127	0.00691	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00124	0.00677	CcSEcCtD
Diltiazem—Osteoarthritis—Fluorouracil—head and neck cancer	0.00124	0.00677	CcSEcCtD
Diltiazem—Injection site reaction—Docetaxel—head and neck cancer	0.00123	0.00669	CcSEcCtD
Diltiazem—Hallucination—Hydroxyurea—head and neck cancer	0.00119	0.00647	CcSEcCtD
Diltiazem—Colitis—Docetaxel—head and neck cancer	0.00119	0.00646	CcSEcCtD
Diltiazem—Cardiac arrest—Fluorouracil—head and neck cancer	0.00118	0.00644	CcSEcCtD
Diltiazem—Neuropathy—Docetaxel—head and neck cancer	0.00116	0.00632	CcSEcCtD
Diltiazem—Alopecia—Vinblastine—head and neck cancer	0.00116	0.0063	CcSEcCtD
Diltiazem—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00111	0.00605	CcSEcCtD
Diltiazem—Lightheadedness—Docetaxel—head and neck cancer	0.00111	0.00602	CcSEcCtD
Diltiazem—Angiopathy—Hydroxyurea—head and neck cancer	0.00108	0.0059	CcSEcCtD
Diltiazem—Ill-defined disorder—Vinblastine—head and neck cancer	0.00106	0.00576	CcSEcCtD
Diltiazem—Alopecia—Hydroxyurea—head and neck cancer	0.00106	0.00575	CcSEcCtD
Diltiazem—Phlebitis—Docetaxel—head and neck cancer	0.00104	0.00567	CcSEcCtD
Diltiazem—Erythema—Hydroxyurea—head and neck cancer	0.00104	0.00566	CcSEcCtD
Diltiazem—Malaise—Vinblastine—head and neck cancer	0.00103	0.0056	CcSEcCtD
Diltiazem—Vertigo—Vinblastine—head and neck cancer	0.00102	0.00558	CcSEcCtD
Diltiazem—Leukopenia—Vinblastine—head and neck cancer	0.00102	0.00556	CcSEcCtD
Diltiazem—Swelling—Docetaxel—head and neck cancer	0.00102	0.00554	CcSEcCtD
Diltiazem—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000989	0.00539	CcSEcCtD
Diltiazem—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000981	0.00534	CcSEcCtD
Diltiazem—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000965	0.00525	CcSEcCtD
Diltiazem—Discomfort—Vinblastine—head and neck cancer	0.000959	0.00522	CcSEcCtD
Diltiazem—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000944	0.00514	CcSEcCtD
Diltiazem—Myocardial infarction—Fluorouracil—head and neck cancer	0.000939	0.00511	CcSEcCtD
Diltiazem—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000939	0.00511	CcSEcCtD
Diltiazem—Malaise—Hydroxyurea—head and neck cancer	0.000938	0.00511	CcSEcCtD
Diltiazem—Urinary tract infection—Fluorouracil—head and neck cancer	0.000931	0.00507	CcSEcCtD
Diltiazem—Conjunctivitis—Fluorouracil—head and neck cancer	0.000931	0.00507	CcSEcCtD
Diltiazem—Leukopenia—Hydroxyurea—head and neck cancer	0.000931	0.00507	CcSEcCtD
Diltiazem—Lethargy—Docetaxel—head and neck cancer	0.000915	0.00499	CcSEcCtD
Diltiazem—Thrombocytopenia—Vinblastine—head and neck cancer	0.000911	0.00496	CcSEcCtD
Diltiazem—Epistaxis—Fluorouracil—head and neck cancer	0.000903	0.00492	CcSEcCtD
Diltiazem—Sinusitis—Fluorouracil—head and neck cancer	0.000899	0.00489	CcSEcCtD
Diltiazem—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000897	0.00489	CcSEcCtD
Diltiazem—Agranulocytosis—Fluorouracil—head and neck cancer	0.000894	0.00487	CcSEcCtD
Diltiazem—Anorexia—Vinblastine—head and neck cancer	0.000887	0.00483	CcSEcCtD
Diltiazem—Discomfort—Hydroxyurea—head and neck cancer	0.000875	0.00476	CcSEcCtD
Diltiazem—Rhinitis—Fluorouracil—head and neck cancer	0.000862	0.00469	CcSEcCtD
Diltiazem—Pharyngitis—Fluorouracil—head and neck cancer	0.000853	0.00465	CcSEcCtD
Diltiazem—Oedema—Hydroxyurea—head and neck cancer	0.000849	0.00462	CcSEcCtD
Diltiazem—Infection—Hydroxyurea—head and neck cancer	0.000843	0.00459	CcSEcCtD
Diltiazem—Paraesthesia—Vinblastine—head and neck cancer	0.000836	0.00455	CcSEcCtD
Diltiazem—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000832	0.00453	CcSEcCtD
Diltiazem—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000831	0.00453	CcSEcCtD
Diltiazem—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000819	0.00446	CcSEcCtD
Diltiazem—Abdominal pain upper—Docetaxel—head and neck cancer	0.000819	0.00446	CcSEcCtD
Diltiazem—Anorexia—Hydroxyurea—head and neck cancer	0.000809	0.00441	CcSEcCtD
Diltiazem—Decreased appetite—Vinblastine—head and neck cancer	0.000809	0.00441	CcSEcCtD
Diltiazem—Cramp muscle—Docetaxel—head and neck cancer	0.000808	0.0044	CcSEcCtD
Diltiazem—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000808	0.0044	CcSEcCtD
Diltiazem—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000808	0.0044	CcSEcCtD
Diltiazem—Nasopharyngitis—Docetaxel—head and neck cancer	0.000802	0.00437	CcSEcCtD
Diltiazem—Constipation—Vinblastine—head and neck cancer	0.000796	0.00433	CcSEcCtD
Diltiazem—Pain—Vinblastine—head and neck cancer	0.000796	0.00433	CcSEcCtD
Diltiazem—Arrhythmia—Fluorouracil—head and neck cancer	0.000768	0.00418	CcSEcCtD
Diltiazem—Feeling abnormal—Vinblastine—head and neck cancer	0.000767	0.00418	CcSEcCtD
Diltiazem—Alopecia—Fluorouracil—head and neck cancer	0.00076	0.00414	CcSEcCtD
Diltiazem—Dyspnoea—Hydroxyurea—head and neck cancer	0.000757	0.00412	CcSEcCtD
Diltiazem—Somnolence—Hydroxyurea—head and neck cancer	0.000755	0.00411	CcSEcCtD
Diltiazem—Erythema—Fluorouracil—head and neck cancer	0.000749	0.00408	CcSEcCtD
Diltiazem—Dyspepsia—Hydroxyurea—head and neck cancer	0.000747	0.00407	CcSEcCtD
Diltiazem—Decreased appetite—Hydroxyurea—head and neck cancer	0.000738	0.00402	CcSEcCtD
Diltiazem—Abdominal pain—Vinblastine—head and neck cancer	0.000736	0.00401	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000733	0.00399	CcSEcCtD
Diltiazem—Fatigue—Hydroxyurea—head and neck cancer	0.000732	0.00398	CcSEcCtD
Diltiazem—Pain—Hydroxyurea—head and neck cancer	0.000726	0.00395	CcSEcCtD
Diltiazem—Constipation—Hydroxyurea—head and neck cancer	0.000726	0.00395	CcSEcCtD
Diltiazem—Weight increased—Docetaxel—head and neck cancer	0.000706	0.00384	CcSEcCtD
Diltiazem—Vision blurred—Fluorouracil—head and neck cancer	0.000705	0.00384	CcSEcCtD
Diltiazem—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000699	0.00381	CcSEcCtD
Diltiazem—Hypersensitivity—Vinblastine—head and neck cancer	0.000686	0.00373	CcSEcCtD
Diltiazem—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000685	0.00373	CcSEcCtD
Diltiazem—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000682	0.00371	CcSEcCtD
Diltiazem—Renal failure—Docetaxel—head and neck cancer	0.00068	0.0037	CcSEcCtD
Diltiazem—Myocardial infarction—Docetaxel—head and neck cancer	0.000678	0.00369	CcSEcCtD
Diltiazem—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000678	0.00369	CcSEcCtD
Diltiazem—Conjunctivitis—Docetaxel—head and neck cancer	0.000672	0.00366	CcSEcCtD
Diltiazem—Body temperature increased—Hydroxyurea—head and neck cancer	0.000671	0.00365	CcSEcCtD
Diltiazem—Leukopenia—Fluorouracil—head and neck cancer	0.00067	0.00365	CcSEcCtD
Diltiazem—Asthenia—Vinblastine—head and neck cancer	0.000668	0.00364	CcSEcCtD
Diltiazem—Epistaxis—Docetaxel—head and neck cancer	0.000652	0.00355	CcSEcCtD
Diltiazem—Agranulocytosis—Docetaxel—head and neck cancer	0.000645	0.00351	CcSEcCtD
Diltiazem—Chest pain—Fluorouracil—head and neck cancer	0.000637	0.00347	CcSEcCtD
Diltiazem—Myalgia—Fluorouracil—head and neck cancer	0.000637	0.00347	CcSEcCtD
Diltiazem—Diarrhoea—Vinblastine—head and neck cancer	0.000637	0.00347	CcSEcCtD
Diltiazem—Discomfort—Fluorouracil—head and neck cancer	0.00063	0.00343	CcSEcCtD
Diltiazem—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000625	0.00341	CcSEcCtD
Diltiazem—Rhinitis—Docetaxel—head and neck cancer	0.000622	0.00339	CcSEcCtD
Diltiazem—Hepatitis—Docetaxel—head and neck cancer	0.000621	0.00338	CcSEcCtD
Diltiazem—Pharyngitis—Docetaxel—head and neck cancer	0.000616	0.00335	CcSEcCtD
Diltiazem—Dizziness—Vinblastine—head and neck cancer	0.000615	0.00335	CcSEcCtD
Diltiazem—Urinary tract disorder—Docetaxel—head and neck cancer	0.000613	0.00334	CcSEcCtD
Diltiazem—Oedema peripheral—Docetaxel—head and neck cancer	0.000611	0.00333	CcSEcCtD
Diltiazem—Oedema—Fluorouracil—head and neck cancer	0.000611	0.00333	CcSEcCtD
Diltiazem—Asthenia—Hydroxyurea—head and neck cancer	0.000609	0.00332	CcSEcCtD
Diltiazem—Urethral disorder—Docetaxel—head and neck cancer	0.000608	0.00331	CcSEcCtD
Diltiazem—Infection—Fluorouracil—head and neck cancer	0.000607	0.00331	CcSEcCtD
Diltiazem—Nervous system disorder—Fluorouracil—head and neck cancer	0.000599	0.00326	CcSEcCtD
Diltiazem—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000598	0.00326	CcSEcCtD
Diltiazem—Visual impairment—Docetaxel—head and neck cancer	0.000598	0.00326	CcSEcCtD
Diltiazem—Tachycardia—Fluorouracil—head and neck cancer	0.000596	0.00325	CcSEcCtD
Diltiazem—Vomiting—Vinblastine—head and neck cancer	0.000592	0.00322	CcSEcCtD
Diltiazem—Erythema multiforme—Docetaxel—head and neck cancer	0.000587	0.0032	CcSEcCtD
Diltiazem—Headache—Vinblastine—head and neck cancer	0.000583	0.00318	CcSEcCtD
Diltiazem—Anorexia—Fluorouracil—head and neck cancer	0.000582	0.00317	CcSEcCtD
Diltiazem—Diarrhoea—Hydroxyurea—head and neck cancer	0.000581	0.00316	CcSEcCtD
Diltiazem—Eye disorder—Docetaxel—head and neck cancer	0.00058	0.00316	CcSEcCtD
Diltiazem—Flushing—Docetaxel—head and neck cancer	0.000576	0.00314	CcSEcCtD
Diltiazem—Cardiac disorder—Docetaxel—head and neck cancer	0.000576	0.00314	CcSEcCtD
Diltiazem—Hypotension—Fluorouracil—head and neck cancer	0.000571	0.00311	CcSEcCtD
Diltiazem—Angiopathy—Docetaxel—head and neck cancer	0.000563	0.00307	CcSEcCtD
Diltiazem—Dizziness—Hydroxyurea—head and neck cancer	0.000561	0.00306	CcSEcCtD
Diltiazem—Mediastinal disorder—Docetaxel—head and neck cancer	0.000559	0.00305	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000557	0.00303	CcSEcCtD
Diltiazem—Arrhythmia—Docetaxel—head and neck cancer	0.000554	0.00302	CcSEcCtD
Diltiazem—Nausea—Vinblastine—head and neck cancer	0.000553	0.00301	CcSEcCtD
Diltiazem—Insomnia—Fluorouracil—head and neck cancer	0.000553	0.00301	CcSEcCtD
Diltiazem—Paraesthesia—Fluorouracil—head and neck cancer	0.000549	0.00299	CcSEcCtD
Diltiazem—Alopecia—Docetaxel—head and neck cancer	0.000548	0.00299	CcSEcCtD
Diltiazem—Dyspnoea—Fluorouracil—head and neck cancer	0.000545	0.00297	CcSEcCtD
Diltiazem—Somnolence—Fluorouracil—head and neck cancer	0.000543	0.00296	CcSEcCtD
Diltiazem—Malnutrition—Docetaxel—head and neck cancer	0.00054	0.00294	CcSEcCtD
Diltiazem—Erythema—Docetaxel—head and neck cancer	0.00054	0.00294	CcSEcCtD
Diltiazem—Vomiting—Hydroxyurea—head and neck cancer	0.00054	0.00294	CcSEcCtD
Diltiazem—Dyspepsia—Fluorouracil—head and neck cancer	0.000538	0.00293	CcSEcCtD
Diltiazem—Rash—Hydroxyurea—head and neck cancer	0.000535	0.00291	CcSEcCtD
Diltiazem—Dermatitis—Hydroxyurea—head and neck cancer	0.000535	0.00291	CcSEcCtD
Diltiazem—Headache—Hydroxyurea—head and neck cancer	0.000532	0.0029	CcSEcCtD
Diltiazem—Decreased appetite—Fluorouracil—head and neck cancer	0.000531	0.00289	CcSEcCtD
Diltiazem—Dysgeusia—Docetaxel—head and neck cancer	0.000529	0.00288	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000527	0.00287	CcSEcCtD
Diltiazem—Pain—Fluorouracil—head and neck cancer	0.000522	0.00284	CcSEcCtD
Diltiazem—Muscle spasms—Docetaxel—head and neck cancer	0.000519	0.00283	CcSEcCtD
Diltiazem—Nausea—Hydroxyurea—head and neck cancer	0.000504	0.00275	CcSEcCtD
Diltiazem—Feeling abnormal—Fluorouracil—head and neck cancer	0.000503	0.00274	CcSEcCtD
Diltiazem—Urticaria—Fluorouracil—head and neck cancer	0.000485	0.00264	CcSEcCtD
Diltiazem—Syncope—Docetaxel—head and neck cancer	0.000484	0.00264	CcSEcCtD
Diltiazem—Leukopenia—Docetaxel—head and neck cancer	0.000484	0.00263	CcSEcCtD
Diltiazem—Body temperature increased—Fluorouracil—head and neck cancer	0.000483	0.00263	CcSEcCtD
Diltiazem—Palpitations—Docetaxel—head and neck cancer	0.000477	0.0026	CcSEcCtD
Diltiazem—Loss of consciousness—Docetaxel—head and neck cancer	0.000475	0.00259	CcSEcCtD
Diltiazem—Cough—Docetaxel—head and neck cancer	0.000471	0.00257	CcSEcCtD
Diltiazem—Arthralgia—Docetaxel—head and neck cancer	0.00046	0.0025	CcSEcCtD
Diltiazem—Chest pain—Docetaxel—head and neck cancer	0.00046	0.0025	CcSEcCtD
Diltiazem—Myalgia—Docetaxel—head and neck cancer	0.00046	0.0025	CcSEcCtD
Diltiazem—Hypersensitivity—Fluorouracil—head and neck cancer	0.00045	0.00245	CcSEcCtD
Diltiazem—Dry mouth—Docetaxel—head and neck cancer	0.00045	0.00245	CcSEcCtD
Diltiazem—Oedema—Docetaxel—head and neck cancer	0.000441	0.0024	CcSEcCtD
Diltiazem—Infection—Docetaxel—head and neck cancer	0.000438	0.00239	CcSEcCtD
Diltiazem—Shock—Docetaxel—head and neck cancer	0.000434	0.00236	CcSEcCtD
Diltiazem—Nervous system disorder—Docetaxel—head and neck cancer	0.000432	0.00235	CcSEcCtD
Diltiazem—Pruritus—Fluorouracil—head and neck cancer	0.000432	0.00235	CcSEcCtD
Diltiazem—Thrombocytopenia—Docetaxel—head and neck cancer	0.000432	0.00235	CcSEcCtD
Diltiazem—Tachycardia—Docetaxel—head and neck cancer	0.00043	0.00234	CcSEcCtD
Diltiazem—Anorexia—Docetaxel—head and neck cancer	0.00042	0.00229	CcSEcCtD
Diltiazem—Diarrhoea—Fluorouracil—head and neck cancer	0.000418	0.00228	CcSEcCtD
Diltiazem—Hypotension—Docetaxel—head and neck cancer	0.000412	0.00224	CcSEcCtD
Diltiazem—Dizziness—Fluorouracil—head and neck cancer	0.000404	0.0022	CcSEcCtD
Diltiazem—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000402	0.00219	CcSEcCtD
Diltiazem—Insomnia—Docetaxel—head and neck cancer	0.000399	0.00217	CcSEcCtD
Diltiazem—Paraesthesia—Docetaxel—head and neck cancer	0.000396	0.00216	CcSEcCtD
Diltiazem—Dyspnoea—Docetaxel—head and neck cancer	0.000393	0.00214	CcSEcCtD
Diltiazem—Somnolence—Docetaxel—head and neck cancer	0.000392	0.00213	CcSEcCtD
Diltiazem—Vomiting—Fluorouracil—head and neck cancer	0.000388	0.00212	CcSEcCtD
Diltiazem—Dyspepsia—Docetaxel—head and neck cancer	0.000388	0.00211	CcSEcCtD
Diltiazem—Rash—Fluorouracil—head and neck cancer	0.000385	0.0021	CcSEcCtD
Diltiazem—Dermatitis—Fluorouracil—head and neck cancer	0.000385	0.0021	CcSEcCtD
Diltiazem—Decreased appetite—Docetaxel—head and neck cancer	0.000383	0.00209	CcSEcCtD
Diltiazem—Headache—Fluorouracil—head and neck cancer	0.000383	0.00208	CcSEcCtD
Diltiazem—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000381	0.00207	CcSEcCtD
Diltiazem—Fatigue—Docetaxel—head and neck cancer	0.00038	0.00207	CcSEcCtD
Diltiazem—Pain—Docetaxel—head and neck cancer	0.000377	0.00205	CcSEcCtD
Diltiazem—Constipation—Docetaxel—head and neck cancer	0.000377	0.00205	CcSEcCtD
Diltiazem—Feeling abnormal—Docetaxel—head and neck cancer	0.000363	0.00198	CcSEcCtD
Diltiazem—Nausea—Fluorouracil—head and neck cancer	0.000363	0.00198	CcSEcCtD
Diltiazem—Body temperature increased—Docetaxel—head and neck cancer	0.000349	0.0019	CcSEcCtD
Diltiazem—Abdominal pain—Docetaxel—head and neck cancer	0.000349	0.0019	CcSEcCtD
Diltiazem—Hypersensitivity—Docetaxel—head and neck cancer	0.000325	0.00177	CcSEcCtD
Diltiazem—Asthenia—Docetaxel—head and neck cancer	0.000316	0.00172	CcSEcCtD
Diltiazem—Pruritus—Docetaxel—head and neck cancer	0.000312	0.0017	CcSEcCtD
Diltiazem—Diarrhoea—Docetaxel—head and neck cancer	0.000302	0.00164	CcSEcCtD
Diltiazem—Dizziness—Docetaxel—head and neck cancer	0.000292	0.00159	CcSEcCtD
Diltiazem—Vomiting—Docetaxel—head and neck cancer	0.00028	0.00153	CcSEcCtD
Diltiazem—Rash—Docetaxel—head and neck cancer	0.000278	0.00151	CcSEcCtD
Diltiazem—Dermatitis—Docetaxel—head and neck cancer	0.000278	0.00151	CcSEcCtD
Diltiazem—Headache—Docetaxel—head and neck cancer	0.000276	0.0015	CcSEcCtD
Diltiazem—Nausea—Docetaxel—head and neck cancer	0.000262	0.00143	CcSEcCtD
Diltiazem—CACNA1C—Developmental Biology—CEBPA—head and neck cancer	5.97e-05	0.00685	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonic acid metabolism—GPX1—head and neck cancer	5.76e-05	0.0066	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonic acid metabolism—CYP1A1—head and neck cancer	5.7e-05	0.00653	CbGpPWpGaD
Diltiazem—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	5.68e-05	0.00652	CbGpPWpGaD
Diltiazem—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	5.61e-05	0.00643	CbGpPWpGaD
Diltiazem—CACNA1S—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	5.51e-05	0.00632	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—NAT2—head and neck cancer	5.23e-05	0.00599	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—NAT2—head and neck cancer	5.16e-05	0.00591	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—MAPK3—head and neck cancer	5.15e-05	0.0059	CbGpPWpGaD
Diltiazem—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	5.14e-05	0.00589	CbGpPWpGaD
Diltiazem—CACNA1S—Alzheimers Disease—TP53—head and neck cancer	5.11e-05	0.00586	CbGpPWpGaD
Diltiazem—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	5.09e-05	0.00583	CbGpPWpGaD
Diltiazem—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.92e-05	0.00564	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—MAPK1—head and neck cancer	4.9e-05	0.00562	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—UROD—head and neck cancer	4.86e-05	0.00558	CbGpPWpGaD
Diltiazem—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.86e-05	0.00557	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	4.68e-05	0.00537	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	4.64e-05	0.00531	CbGpPWpGaD
Diltiazem—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	4.61e-05	0.00528	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—MAPK3—head and neck cancer	4.57e-05	0.00523	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—NAT2—head and neck cancer	4.53e-05	0.00519	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	4.47e-05	0.00512	CbGpPWpGaD
Diltiazem—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.4e-05	0.00504	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—MAPK1—head and neck cancer	4.35e-05	0.00498	CbGpPWpGaD
Diltiazem—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	4.34e-05	0.00497	CbGpPWpGaD
Diltiazem—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.04e-05	0.00463	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—NAT2—head and neck cancer	4.04e-05	0.00463	CbGpPWpGaD
Diltiazem—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	4.01e-05	0.00459	CbGpPWpGaD
Diltiazem—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.99e-05	0.00458	CbGpPWpGaD
Diltiazem—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.99e-05	0.00457	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	3.99e-05	0.00457	CbGpPWpGaD
Diltiazem—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	3.95e-05	0.00453	CbGpPWpGaD
Diltiazem—CACNA1C—NCAM signaling for neurite out-growth—HRAS—head and neck cancer	3.93e-05	0.00451	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—NAT2—head and neck cancer	3.72e-05	0.00426	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—NAT2—head and neck cancer	3.69e-05	0.00422	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	3.67e-05	0.0042	CbGpPWpGaD
Diltiazem—CACNA1C—Alzheimers Disease—TP53—head and neck cancer	3.65e-05	0.00418	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	3.64e-05	0.00417	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	3.57e-05	0.00409	CbGpPWpGaD
Diltiazem—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.56e-05	0.00408	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	3.52e-05	0.00404	CbGpPWpGaD
Diltiazem—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.39e-05	0.00388	CbGpPWpGaD
Diltiazem—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	3.39e-05	0.00388	CbGpPWpGaD
Diltiazem—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	3.34e-05	0.00383	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	3.32e-05	0.0038	CbGpPWpGaD
Diltiazem—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.28e-05	0.00376	CbGpPWpGaD
Diltiazem—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	3.27e-05	0.00375	CbGpPWpGaD
Diltiazem—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	3.25e-05	0.00372	CbGpPWpGaD
Diltiazem—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	3.02e-05	0.00347	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	3.02e-05	0.00346	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—UROD—head and neck cancer	2.98e-05	0.00341	CbGpPWpGaD
Diltiazem—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	2.76e-05	0.00316	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—NOTCH1—head and neck cancer	2.67e-05	0.00306	CbGpPWpGaD
Diltiazem—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	2.64e-05	0.00303	CbGpPWpGaD
Diltiazem—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	2.61e-05	0.00299	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	2.58e-05	0.00296	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	2.55e-05	0.00292	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—CASP8—head and neck cancer	2.51e-05	0.00288	CbGpPWpGaD
Diltiazem—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	2.45e-05	0.00281	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—NAT2—head and neck cancer	2.43e-05	0.00279	CbGpPWpGaD
Diltiazem—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	2.41e-05	0.00277	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	2.4e-05	0.00275	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	2.24e-05	0.00256	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	2.21e-05	0.00253	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—VEGFA—head and neck cancer	2.19e-05	0.00251	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—UROD—head and neck cancer	2.15e-05	0.00247	CbGpPWpGaD
Diltiazem—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	2.14e-05	0.00246	CbGpPWpGaD
Diltiazem—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	2.12e-05	0.00243	CbGpPWpGaD
Diltiazem—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	2.09e-05	0.0024	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MAPK3—head and neck cancer	2.07e-05	0.00237	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—NAT2—head and neck cancer	2.02e-05	0.00232	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	2e-05	0.00229	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—MAPK1—head and neck cancer	1.97e-05	0.00226	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—EGFR—head and neck cancer	1.97e-05	0.00226	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	1.97e-05	0.00226	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—NOTCH1—head and neck cancer	1.9e-05	0.00218	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—IL2—head and neck cancer	1.9e-05	0.00217	CbGpPWpGaD
Diltiazem—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	1.89e-05	0.00217	CbGpPWpGaD
Diltiazem—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	1.87e-05	0.00214	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—UROD—head and neck cancer	1.87e-05	0.00214	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	1.86e-05	0.00213	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	1.84e-05	0.0021	CbGpPWpGaD
Diltiazem—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	1.82e-05	0.00209	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	1.82e-05	0.00209	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	1.81e-05	0.00208	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	1.81e-05	0.00208	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	1.8e-05	0.00206	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—DPYD—head and neck cancer	1.77e-05	0.00203	CbGpPWpGaD
Diltiazem—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	1.74e-05	0.002	CbGpPWpGaD
Diltiazem—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	1.73e-05	0.00198	CbGpPWpGaD
Diltiazem—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	1.72e-05	0.00197	CbGpPWpGaD
Diltiazem—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	1.7e-05	0.00195	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—YAP1—head and neck cancer	1.68e-05	0.00193	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—UROD—head and neck cancer	1.66e-05	0.00191	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—UROD—head and neck cancer	1.62e-05	0.00186	CbGpPWpGaD
Diltiazem—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	1.61e-05	0.00185	CbGpPWpGaD
Diltiazem—CACNA1S—Axon guidance—HRAS—head and neck cancer	1.58e-05	0.00181	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—VEGFA—head and neck cancer	1.56e-05	0.00179	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—VEGFA—head and neck cancer	1.56e-05	0.00179	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—STAT3—head and neck cancer	1.55e-05	0.00177	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—UROD—head and neck cancer	1.53e-05	0.00175	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—UROD—head and neck cancer	1.52e-05	0.00174	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MAPK3—head and neck cancer	1.48e-05	0.00169	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MAPK3—head and neck cancer	1.48e-05	0.00169	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.45e-05	0.00166	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—MAPK1—head and neck cancer	1.41e-05	0.00161	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—EGFR—head and neck cancer	1.41e-05	0.00161	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—MAPK1—head and neck cancer	1.41e-05	0.00161	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—EGFR—head and neck cancer	1.4e-05	0.00161	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.29e-05	0.00148	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	1.24e-05	0.00142	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—NAT2—head and neck cancer	1.24e-05	0.00142	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	1.2e-05	0.00138	CbGpPWpGaD
Diltiazem—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	1.19e-05	0.00136	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	1.18e-05	0.00136	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	1.18e-05	0.00135	CbGpPWpGaD
Diltiazem—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	1.14e-05	0.0013	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—HRAS—head and neck cancer	1.13e-05	0.00129	CbGpPWpGaD
Diltiazem—CACNA1C—Axon guidance—HRAS—head and neck cancer	1.13e-05	0.00129	CbGpPWpGaD
Diltiazem—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	1.12e-05	0.00129	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—VEGFA—head and neck cancer	1.11e-05	0.00128	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—STAT3—head and neck cancer	1.1e-05	0.00126	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—DPYD—head and neck cancer	1.08e-05	0.00124	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	1.06e-05	0.00122	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MAPK3—head and neck cancer	1.05e-05	0.00121	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—YAP1—head and neck cancer	1.03e-05	0.00118	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	1.01e-05	0.00116	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—TYMS—head and neck cancer	1.01e-05	0.00116	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—MAPK1—head and neck cancer	1e-05	0.00115	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—EGFR—head and neck cancer	1e-05	0.00115	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—UROD—head and neck cancer	1e-05	0.00115	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GSTM1—head and neck cancer	9.98e-06	0.00114	CbGpPWpGaD
Diltiazem—CACNA1S—Developmental Biology—AKT1—head and neck cancer	9.96e-06	0.00114	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—GPX1—head and neck cancer	9.55e-06	0.0011	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—CYP1A1—head and neck cancer	9.46e-06	0.00108	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	9.13e-06	0.00105	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—NAT2—head and neck cancer	8.94e-06	0.00102	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	8.81e-06	0.00101	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.23e-06	0.000943	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.14e-06	0.000933	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—HRAS—head and neck cancer	8.05e-06	0.000923	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7.96e-06	0.000912	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—DPYD—head and neck cancer	7.84e-06	0.000899	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—NAT2—head and neck cancer	7.74e-06	0.000888	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	7.53e-06	0.000863	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—YAP1—head and neck cancer	7.44e-06	0.000853	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.34e-06	0.000841	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.27e-06	0.000833	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	7.16e-06	0.000821	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	7.16e-06	0.000821	CbGpPWpGaD
Diltiazem—CACNA1C—Developmental Biology—AKT1—head and neck cancer	7.11e-06	0.000815	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—NAT2—head and neck cancer	6.91e-06	0.000792	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—DPYD—head and neck cancer	6.79e-06	0.000778	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—NAT2—head and neck cancer	6.75e-06	0.000773	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.69e-06	0.000767	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.63e-06	0.00076	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—YAP1—head and neck cancer	6.44e-06	0.000739	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—NAT2—head and neck cancer	6.36e-06	0.000729	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—NAT2—head and neck cancer	6.3e-06	0.000722	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	6.22e-06	0.000712	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—TYMS—head and neck cancer	6.18e-06	0.000708	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GSTM1—head and neck cancer	6.11e-06	0.0007	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—DPYD—head and neck cancer	6.06e-06	0.000695	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	6.01e-06	0.000689	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—DPYD—head and neck cancer	5.92e-06	0.000678	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—GPX1—head and neck cancer	5.85e-06	0.000671	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—CYP1A1—head and neck cancer	5.79e-06	0.000664	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—YAP1—head and neck cancer	5.75e-06	0.000659	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTGS2—head and neck cancer	5.62e-06	0.000645	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—YAP1—head and neck cancer	5.61e-06	0.000643	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—DPYD—head and neck cancer	5.58e-06	0.000639	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—DPYD—head and neck cancer	5.53e-06	0.000633	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—YAP1—head and neck cancer	5.29e-06	0.000606	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—YAP1—head and neck cancer	5.24e-06	0.000601	CbGpPWpGaD
Diltiazem—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	5.08e-06	0.000582	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PTEN—head and neck cancer	4.91e-06	0.000562	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.84e-06	0.000555	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—TYMS—head and neck cancer	4.47e-06	0.000512	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GSTM1—head and neck cancer	4.42e-06	0.000506	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.32e-06	0.000495	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—GPX1—head and neck cancer	4.23e-06	0.000485	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.22e-06	0.000484	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—CYP1A1—head and neck cancer	4.19e-06	0.00048	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—NAT2—head and neck cancer	4.16e-06	0.000476	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.94e-06	0.000452	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—TYMS—head and neck cancer	3.87e-06	0.000444	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GSTM1—head and neck cancer	3.83e-06	0.000438	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.77e-06	0.000432	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—GPX1—head and neck cancer	3.66e-06	0.00042	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—DPYD—head and neck cancer	3.65e-06	0.000418	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—CYP1A1—head and neck cancer	3.63e-06	0.000416	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—PIK3CA—head and neck cancer	3.46e-06	0.000397	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—YAP1—head and neck cancer	3.46e-06	0.000396	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—TYMS—head and neck cancer	3.45e-06	0.000396	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTGS2—head and neck cancer	3.44e-06	0.000395	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.44e-06	0.000394	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GSTM1—head and neck cancer	3.41e-06	0.000391	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—TYMS—head and neck cancer	3.37e-06	0.000386	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GSTM1—head and neck cancer	3.33e-06	0.000382	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—GPX1—head and neck cancer	3.27e-06	0.000375	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—CYP1A1—head and neck cancer	3.24e-06	0.000371	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—GPX1—head and neck cancer	3.19e-06	0.000366	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—TYMS—head and neck cancer	3.18e-06	0.000364	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—CYP1A1—head and neck cancer	3.16e-06	0.000362	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—TYMS—head and neck cancer	3.15e-06	0.000361	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GSTM1—head and neck cancer	3.14e-06	0.00036	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GSTM1—head and neck cancer	3.11e-06	0.000357	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—GPX1—head and neck cancer	3.01e-06	0.000345	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PTEN—head and neck cancer	3e-06	0.000344	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—GPX1—head and neck cancer	2.98e-06	0.000342	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.98e-06	0.000341	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—CYP1A1—head and neck cancer	2.98e-06	0.000341	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—CYP1A1—head and neck cancer	2.95e-06	0.000338	CbGpPWpGaD
Diltiazem—CACNA1C—Metabolism—AKT1—head and neck cancer	2.83e-06	0.000324	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.66e-06	0.000305	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTGS2—head and neck cancer	2.49e-06	0.000285	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.42e-06	0.000278	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PTEN—head and neck cancer	2.17e-06	0.000249	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTGS2—head and neck cancer	2.16e-06	0.000247	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—PIK3CA—head and neck cancer	2.12e-06	0.000243	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—TYMS—head and neck cancer	2.08e-06	0.000238	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GSTM1—head and neck cancer	2.05e-06	0.000235	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—GPX1—head and neck cancer	1.97e-06	0.000225	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.95e-06	0.000223	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.92e-06	0.000221	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PTEN—head and neck cancer	1.88e-06	0.000216	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTGS2—head and neck cancer	1.88e-06	0.000215	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.77e-06	0.000203	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.76e-06	0.000201	CbGpPWpGaD
Diltiazem—CYP3A7—Metabolism—AKT1—head and neck cancer	1.73e-06	0.000198	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PTEN—head and neck cancer	1.68e-06	0.000192	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PTEN—head and neck cancer	1.64e-06	0.000188	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PTEN—head and neck cancer	1.54e-06	0.000177	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.53e-06	0.000176	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PTEN—head and neck cancer	1.53e-06	0.000175	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—PIK3CA—head and neck cancer	1.33e-06	0.000152	CbGpPWpGaD
Diltiazem—CYP3A5—Metabolism—AKT1—head and neck cancer	1.25e-06	0.000143	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—PIK3CA—head and neck cancer	1.18e-06	0.000136	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTGS2—head and neck cancer	1.16e-06	0.000133	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.16e-06	0.000132	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.09e-06	0.000125	CbGpPWpGaD
Diltiazem—CYP2C8—Metabolism—AKT1—head and neck cancer	1.08e-06	0.000124	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.08e-06	0.000124	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PTEN—head and neck cancer	1.01e-06	0.000116	CbGpPWpGaD
Diltiazem—CYP2C19—Metabolism—AKT1—head and neck cancer	9.67e-07	0.000111	CbGpPWpGaD
Diltiazem—ABCB1—Metabolism—AKT1—head and neck cancer	9.44e-07	0.000108	CbGpPWpGaD
Diltiazem—CYP2D6—Metabolism—AKT1—head and neck cancer	8.9e-07	0.000102	CbGpPWpGaD
Diltiazem—CYP2C9—Metabolism—AKT1—head and neck cancer	8.82e-07	0.000101	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—PIK3CA—head and neck cancer	7.12e-07	8.16e-05	CbGpPWpGaD
Diltiazem—CYP3A4—Metabolism—AKT1—head and neck cancer	5.82e-07	6.67e-05	CbGpPWpGaD
